Home high-cost drugs

Keyword: high-cost drugs

17 results found

An article on the potential impacts of a pension super-priority bill was the most-read story on BenefitsCanada.com over the last week. Here are the five most popular news stories of the week: 1. Pension super-priority bill passes in House of Commons 2. Ontario municipality establishing six-week indoor mask requirement for city employees 3. CIBC supporting employee health with wellness […]

  • By: Staff
  • December 2, 2022 December 1, 2022
  • 09:00

The increasing use of high-cost medicines is the primary cost driver for all Canadian drug plans, according to a new report by the Patented Medicine Prices Review Board. It found drug costs for public plans rose by 5.3 per cent in 2019/20, with high-cost medicines accounting for 6.3 per cent of the increase. Among private […]

  • By: Staff
  • November 25, 2022 November 24, 2022
  • 09:00

Amid the increasing introduction of specialized medicines in Canada, key stakeholders in the private payer health-care sector are enhancing their collaborations to maintain the value of private drug coverage, said Joe Farago, executive director of private payers and investment at Innovative Medicines Canada, during a webinar by the Group Insurance Pharmaceutical Committee this week. “[The […]

Copyright_Aleksandr Kalugin_123RF

Imagine that a few pills a day could transform an employee’s life — that they could get back to work, perform better, have fewer sick days, be more present and avoid continuously deteriorating health. Now, what if this life-changing medicine is for a rare disease that isn’t covered under the employee’s benefits plan because of […]

Total drug costs grew to $2 billion in 2021, rising steadily from $1.4 billion in 2017, according to Green Shield Canada’s annual drug trends report. The report, which is based on claims reported by Green Shield Canada, found the number of claimants also increased from 1.9 million to 2.1 million over the same period. While […]

  • By: Staff
  • September 23, 2022 September 22, 2022
  • 09:00

Canadian life and health insurers processed nearly $600 million in claims related to mental health in 2021, up 45 per cent since 2020 and 75 per cent since 2019, according to the Canadian Life and Health Insurance Association’s annual fact book. “2021 was a year of recovery and insurers have been proud partners helping employers […]

  • By: Staff
  • September 16, 2022 September 15, 2022
  • 09:00

Average benefits costs for U.S. employers will increase 6.5 per cent — or more than $13,800 per employee — in 2023, according to a new report by Aon. This projection is more than double the three per cent increase to health-care budgets from 2021 to 2022, but below the 9.1 inflation figure reported through the consumer price […]

  • By: Staff
  • August 24, 2022 August 23, 2022
  • 09:00

The amendments to the Patented Medicine Prices Review Board regulations are officially taking effect July 1, after being delayed multiple times. The changes, which were originally proposed in 2019, are the first significant update to the regulations in more than 30 years. After consulting with stakeholders, Health Canada will be moving forward with the implementation of […]

As the coronavirus pandemic continues, fewer Canadian benefits plan members are making drug claims, according to Telus Health’s annual drug trends report. The report, based on the drug claims activity of more than 10 million plan members in 2021, found just 56 per cent made a claim in 2021, reflecting a decreased frequency of in-person […]

  • By: Staff
  • June 23, 2022 June 22, 2022
  • 09:00

While medications used for treating inflammatory disease accounted for just 0.7 per cent of claims across Telus Health’s Canadian block of business in 2021, they represent the largest percentage of eligible drug costs at 12.6 per cent, due to the prevalence of high-cost treatments in this drug class. By comparison, diabetes medications accounted for 12 […]